My doctor decided to check my levels of medication and they were slightly low at first, so they just increased the frequency from 7 to 6 weeks. That didn't help, so they decided to up the dosage from 5mg/kg to 10 mg/kg. As I type this, I am getting my first infusion since they decided to increase the dosage to 10mg/kg. So we'll see how it goes. I think it should get me stable enough again, but time will tell.
Your insurance company clearly wanted to save themselves money by forcing you to switch to the cheaper biosimilar drug. But looks like it might end up costing them the same or even more money, because you've had to use more drug more often to try to stay in remission. And while they are cheaper than the branded drugs, biosimilars are still pretty expensive.
Might be a case of a penny wise and pound foolish insurance company.
It sounds like the active ingredient is at a lower level in the inflectra than in the remicade. Does anyone have proof of this?